Authors


Aung Naing Lin, MD

Latest:

AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient Setting

Using Plan-Do-Study-Act cycles, the studied intervention reduced hospital inpatient telemetry time by 51.25% while increasing American Heart Association (AHA) guideline–based usage.


Danielle Feffer, BA

Latest:

Characteristics, Utilization, and Concentration of Outpatient Care for Dual-Eligible Medicare Beneficiaries

Outpatient care for dual-eligible beneficiaries is concentrated among a small group of physicians, and these beneficiaries receive less subspecialty care despite having more chronic conditions.


Joohyun Park, PhD

Latest:

Part D Coverage Gap Reform: Trends in Drug Use and Expenditures

This study analyzed annual trends in the distribution of beneficiaries entering each benefit phase, drug utilization, and expenditures among Part D beneficiaries from 2008 to 2015.


Patrick White, MD, HMDC

Latest:

Using Electronic Health Records and Claims Data to Identify High-risk Patients Likely to Benefit From Palliative Care

Deep learning algorithms could improve palliative care by predicting mortality from electronic health records and claims data.



Celeste Campos-Castillo, PhD

Latest:

Telehealth Use in 2022 Among US Adults by Sexual Orientation

In a 2022 survey representative of US adults, sexual minority individuals reported greater rates of telehealth use, especially for mental health visits, than heterosexual individuals.


Marisa Davis, BSPH

Latest:

Disconnects Between Provider Network Directories and Patient Preferences

This study found widespread instances of disconnect in online provider directories between information needed by patients and data availability.


Nancy Ross, PharmD, BCACP, MSCS, CSP

Latest:

Future of MS Management

Key opinion leaders in MS provide closing thoughts on the future of MS treatment including digital therapeutics, new generics, and pipeline drugs on the horizon.


Frederick L. Locke, MD
Frederick L. Locke, MD

Latest:

Gene Editing for Safer CAR T-Cell Therapy in Large B-Cell Lymphoma

Cemacabtagene ansegedleucel, an allogeneic chimeric antigen receptor (CAR) T-cell therapy, is being investigated in relapsed/refractory large B-cell lymphoma.


Kevin M. Chiang, PharmD, MBA

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.


Soraida Khalaily, MD

Latest:

Promoters of Therapeutic Inertia in Managing Hypertension: A Consensus-Based Study

The authors identified consensus-based promoters of clinical inertia in managing hypertension. Policy makers should address these promoters to improve health-related outcomes in hypertension.


Lambros Chrones, MD

Latest:

Mental Health Diagnoses and Services Utilization Vary by Wage Level

Insured lower-wage employees had lower prevalence of mental health conditions but greater severity, with more hospital admissions and emergency department visits than high-wage employees.


Ajeet Gajra, MD

Latest:

Oncologists’ Perceptions and Utilization of US Therapeutic Oncology Biosimilars

Biosimilar use in clinical practice is determined by oncologists’ perceptions of and willingness to prescribe them. The authors investigated US oncologists’ perceptions and use of biosimilars.


Rebecca Flournoy, MPH

Latest:

Telehealth Insights From an Integrated Care System

Experiences from a large, integrated, value-based health system suggest that telehealth can be an effective care delivery approach. Public policies can improve telehealth access and care.


Randall Owen, PhD

Latest:

Reply to “Industry-Informed Perspectives on the Benefits of Rideshare-Based Medical Transportation”

The authors of “Rideshare Transportation to Health Care: Evidence From a Medicaid Implementation” respond to a letter to the editor.


Jill Soderquist, MBA

Latest:

Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans

This study provides insight on the experiences of patients of a national health plan with 2 structural determinants of health—health care discrimination and health literacy—and how those interact with social determinants of health and patient demographics.


DeShawn Wilbern, MBA

Latest:

Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America

CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.


John N. Mafi, MD, MPH

Latest:

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.


Chiu-Mei Yeh, MS

Latest:

Hospital Partnership and Patient Outcomes Among Postacute Patients With Stroke

This article explores the patient-sharing relationships between acute hospitals and postacute hospitals and how these relationships influence patient discharge outcomes.


Jeanne Jiang, MS

Latest:

Outcomes in Patients With IBD Stratified by Risk of Disease Progression

This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies.



James Frisbie, MD

Latest:

Incidence and Cost of Potentially Avoidable Emergency Department Visits for Urolithiasis

This study characterizes the incidence and associated factors of urolithiasis-related emergency department visits that are potentially preventable with appropriate ambulatory care and calculates their cumulative costs.


Bob Kronemyer

Latest:

Frequency of Condomless Sex Among Women Using Reversible Methods of Contraception

A substudy of the Evidence for Contraceptive Options and HIV Outcomes trial, which compared 3 highly effective, reversible methods of contraception, concluded that women assigned either a copper intrauterine device or the levonorgestrel implant may have had condomless sex more frequently than women assigned to intramuscular depo-medroxyprogesterone acetate.



Bo Lv, PhD

Latest:

How Do Primary Hospitals Enact Early Response to the Relaxation of COVID-19 Prevention and Control Measures? The Experience From Chengdu, China

This article examines how primary hospitals in Chengdu, China, responded to the relaxation of COVID-19 prevention and control measures in December 2022.


Austin S. Kilaru, MD

Latest:

An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19

For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.


Wen-Chih Wu, MD, MPH

Latest:

Implementation of Early Follow-up Care After Heart Failure Hospitalization

An early heart failure follow-up intervention succeeded in increasing referral to and completion of cardiology appointments within 7 days of discharge. The intervention was associated with lower risk of 30-day all-cause emergency department visits, all-cause hospitalizations, or death.


Aditi P. Sen, PhD, MA

Latest:

Medicare Advantage Coverage Restrictions for the Costliest Physician-Administered Drugs

Four large Medicare Advantage insurers manage access to expensive physician-administered drugs with a combination of prior authorization, step therapy, and Part D formulary design.


Eugene Wright, MD

Latest:

Flash CGM Associated With Event Reduction in Nonintensive Diabetes Therapy

Analysis of the MarketScan database showed a strong association between flash continuous glucose monitoring (CGM) use and significant reductions in diabetes-related events and hospitalizations in a cohort of 10,282 adults with type 2 diabetes.


Ryan Haumschild, PharmD, MS, MBA, CPEL

Latest:

Future Directions and Overcoming Challenges in BTK Inhibitor Therapy

Panelists discuss challenges oncologists face in managing treatment-naive patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), including balancing efficacy with adverse effect profiles, and highlight strategies such as multidisciplinary collaboration and access to updated treatment guidelines to address these issues while also expressing eagerness for future advancements in Bruton tyrosine kinase (BTK) inhibitors and the need for further research to refine treatment strategies and improve patient outcomes.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo